Science

Edwards Lifesciences Corporation (EW) CEO Michael A. Mussallem Sells 32900 Shares

Recently, In analysts note issued to clients on Thursday morning, Edwards Lifesciences (NYSE:EW) shares have had their "Overweight" Rating reconfirmed by research professionals at Morgan Stanley, who now has a $120 target price on firm. The firm owned 7,367 shares of the medical research company's stock after purchasing an additional 1,245 shares during the period. (NYSE:EW) by 82.5% during the second quarter, according to its most recent Form 13F filing with the SEC.

Other large investors have also recently bought and sold shares of the company. AHL Partners LLP now owns 24,022 shares of the medical research company's stock worth $2,395,000 after buying an additional 16,633 shares during the last quarter. As of the end of the quarter Raymond James Financial Services Advisors, Inc. had disposed of a total of 2,245 shares trimming its holdings by 18.7%. Finally, Highbridge Capital Management LLC purchased a new position in Edwards Lifesciences Corp. during the second quarter worth $1,260,000. Alexandria Capital LLC now owns 1,146 shares of the medical research company's stock worth $136,000 after buying an additional 19 shares during the period. Cornerstone Advisors Inc. raised its holdings in shares of Edwards Lifesciences Corporation by 25.1% in the second quarter. Alexandria Capital LLC raised its position in shares of Edwards Lifesciences Corporation by 1.7% during the 2nd quarter.

A number of research analysts have issued reports on the company. BTIG Research restated a "buy" rating and issued a $110.00 target price on shares of Edwards Lifesciences Corp.in a research note on Friday, October 28th. Zacks Investment Research upgraded shares of Edwards Lifesciences Corporation from a "hold" rating to a "buy" rating and set a $130.00 target price for the company in a research report on Tuesday, July 18th. Canaccord Genuity maintained the stock with "Buy" rating in Tuesday, June 27 report. October 25 investment analysts at Barclays left the stock rating at "Hold" and moved down the price target to $115.00 from $120.00.

WARNING: This news story was first posted by Week Herald and is owned by of Week Herald. If you are reading this report on another publication, it was stolen and reposted in violation of United States and global copyright and trademark laws. The stock of Edwards Lifesciences Corp (NYSE:EW) earned "Neutral" rating by Guggenheim on Thursday, June 9. 1,600,143 shares of the stock were exchanged. Edwards Lifesciences Corp has $195 highest and $86 lowest target. It is now trading at $101.63 marginally under the 50 day moving average of $110.17 and which is just under the 200 day moving average of $112.73.

The company's P/E ratio is 30.82 and market capitalization is 21.46B.

Edwards Lifesciences Corporation (EW) traded up 0.54% during trading on Tuesday, reaching $102.18. The medical research company reported $0.84 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.02). The stock of Edwards Lifesciences Corp (NYSE:EW) has "Overweight" rating given on Thursday, October 26 by Morgan Stanley. The firm earned $739.40 million during the quarter, compared to analysts' expectations of $749.14 million. Edwards Lifesciences Corporation's revenue for the quarter was up 11.1% on a year-over-year basis. On average, equities research analysts anticipate that Edwards Lifesciences Corporation will post $3.75 earnings per share for the current fiscal year.

On Wednesday, August 9th, Michael A. Mussallem sold 32,900 shares of Edwards Lifesciences Corporation stock.

In related news, VP Huimin Wang sold 13,650 shares of the business's stock in a transaction on Monday, November 7th. The shares were sold at an average price of $100.93, for a total value of $3,320,597.00. Wood, CVP, THV Replacement disclosed the sale of 18,960 shares of (EW). During the same quarter past year, the company earned $0.68 earnings per share. The Business's Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland.

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. Its segments include United States, Europe, Japan and Rest of World.

A number of hedge funds have recently modified their holdings of EW.



Like this

loading...
loading...

Latest


01 November 2017
Uber CEO Says Company's Future In Brazil In The Balance
If the Senate votes to approve the bill, it will be up to President Michel Temer to sign or veto the legislation or parts of it. Uber said it has paid BRL 495 million ($150 million) in federal and municipal taxes so far this year.

01 November 2017
Analyst Earnings Estimates Coverage: Gramercy Property Trust, Inc. (GPT)
JMP Securities reiterated a "buy" rating on shares of Gramercy Property Trust in a research report on Tuesday, September 13th. The company had revenue of $131.40 million during the quarter, compared to analysts' expectations of $136.30 million.

01 November 2017
United States Heat Pump Water Heaters Market Report 2017 | Qualitative Analysis
An in-depth analysis of forecast market information will provide the data related to the Oil Pump investment feasibility study. Marketing strategies, emerging market segments and comprehensive analysis of Oil Pump will lead to market development.

01 November 2017
Seagate Technology PLC (STX) Given Average Rating of "Hold" by Analysts
The Company also provides data storage services for businesses, including online backup, data protection and recovery solutions. Following the sale, the director now directly owns 3,316 shares of the company's stock, valued at approximately $129,357.16.

01 November 2017
Former Mayor Yarber paddles, holds down auto burglar until police arrive
Asked whether she had ever been spanked by her dad, she said: "I received whoopins, but not with that paddle". When police arrived this time, Yarber said the first officer told Bibbs, "Wrong house, homeboy".

01 November 2017
Skechers USA, Inc. (NYSE:SKX)
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website . Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Skechers U.S.A.by 12.3% in the second quarter.

01 November 2017
ICICI Bank Limited (IBN) stock ends Yesterday with change of 2.73%
The expected future growth in earnings per share ("EPS") is an incredibly important factor.in identifying an under-valued stock. ICICI Bank Limited (NYSE: IBN ) gained 2.73% in yesterday's session, going up from its prior closing price of $8.80 to $9.04.

01 November 2017
Justin Meram, Ola Kamara strike as Columbus beats NYCFC 4-1
When the tie returns to Yankee Stadium, the hosts will also have to deal without the services ofAlexander Callens. His team has scored two goals just once in their last 10 games, an issue he readily identified.

01 November 2017
CNY Heartbeat Poll: Kevin Spacey comes out to mask sexual assault allegations?
To make things worse, a lot of news mediums are catching heat from how they are covering and presenting the story. Neither Spacey nor his representatives responded to multiple requests for comment, BuzzFeed News' Adam B.

01 November 2017
Denny Hamlin Accepts Blame Wrecking Chase Elliott At Martinsville
Shortly after all of the post-race shenanigans were finished, Hamlin sent out a message on social media apologizing to Elliott and his fans for the spin.